Pharmaceutical Drug Development Division

JC BioSciences focuses on re-purposing existing drugs that have not fulfilled their potential due to limiting factors, such as poor bioavailability or failure to timely pursue regulatory approvals. The company works on molecule improvements, synergistic combination drugs, drug delivery enhancement and new disease treatment indications. All the new drugs are currently in preclinical development at JC BioSciences.